Edward Spangenthal is a Cardiology physician affiliated with Roswell Park Comprehensive Cancer Center. OpenAlex indexes 15 publications with 379 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
295 Essjay Rd
Williamsville, NY 142218216
Telephone
716-630-1156Registry record last updated 18 Jul 2013.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20251 payment
- Boston Scientific CorporationProgram year20231 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.4%Beta blocker25.3%Metoprolol Succinate46%Carvedilol36%Metoprolol Tartrate18%Part D≥50 patientsCalcium channel blocker13.8%Amlodipine Besylate67%Diltiazem 24hr Er (Cd)21%Nifedipine Er13%Part D<11 patients+ 10 more classes in this area
Blood & clotting
16.5%Factor Xa inhibitor14.8%Eliquis83%Xarelto17%Part D<11 patientsDirect thrombin inhibitors1.7%Dabigatran Etexilate100%Part D<11 patientsMetabolism & gastrointestinal
5.1%Potassium supplement2.8%Potassium Chloride100%Part D<11 patientsSGLT2 inhibitor2.4%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Repeat AngioVac Debulking of a Large Right Atrial Thrombus With Extension From the Hepatic Vein
Case Reports in Cardiology
2025 - Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis
Journal for ImmunoTherapy of Cancer
2021 - Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature
Case Reports in Oncology
2019 - Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia
Leukemia Research Reports
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Philip McCarthy, MD
Roswell Park Comprehensive Cancer Center
Saby George, MD
Roswell Park Comprehensive Cancer Center
Eunice Wang, MD
Roswell Park Comprehensive Cancer Center
Shashikant Lele, MD
Roswell Park Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”